| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ageing and menopause considerations for women with HIV in the UK
|
Sherr, L.
|
|
|
|
4 |
p. 215-218
|
artikel
|
| 2 |
A landscape analysis of HIV cure-related clinical research in 2019
|
Barr, Liz
|
|
|
|
4 |
p.
|
artikel
|
| 3 |
A landscape analysis of HIV cure-related clinical trials and observational studies in 2018
|
Barr, Liz
|
|
|
|
4 |
p. 212-219
|
artikel
|
| 4 |
Altruism: Scoping review of the literature and future directions for HIV cure-related research
|
Dubé, Karine
|
|
|
|
4 |
p.
|
artikel
|
| 5 |
Antiviral activity of nitazoxanide against Morbillivirus infections
|
Stelitano, Debora
|
|
|
|
4 |
p.
|
artikel
|
| 6 |
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
|
Stirrup, Oliver T.
|
|
|
|
4 |
p. 204-211
|
artikel
|
| 7 |
Barriers and best practices of transitioning perinatally HIV-infected adolescents to adult care in Asia-Pacific
|
Bunupuradah, Torsak
|
|
|
|
4 |
p. 284-285
|
artikel
|
| 8 |
Bone mineral density optimisation in adults with perinatally acquired HIV infection in routine care
|
Pasvol, Thomas J.
|
|
|
|
4 |
p. 262
|
artikel
|
| 9 |
Challenges of ending AIDS in Thailand
|
Sai Tin, Sim
|
|
|
|
4 |
p. 250
|
artikel
|
| 10 |
Changes in the haematological parameters of HIV-1 infected children at 6 and 12 months of antiretroviral therapy in a large clinic cohort, North-Central Nigeria
|
Ebonyi, Augustine O.
|
|
|
|
4 |
p. 208-211
|
artikel
|
| 11 |
Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in a real-world setting
|
Rolle, Charlotte-Paige
|
|
|
|
4 |
p.
|
artikel
|
| 12 |
Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
|
Tosiano, Melissa A.
|
|
|
|
4 |
p.
|
artikel
|
| 13 |
Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum
|
Martin, Genevieve E.
|
|
|
|
4 |
p. 236-241
|
artikel
|
| 14 |
Cytomegalovirus and paediatric HIV infection
|
Slyker, J.e.n.n.i.f.e.r.A.
|
|
|
|
4 |
p. 208-214
|
artikel
|
| 15 |
Cytomegalovirus vaccines under clinical development
|
Schleiss, Mark R.
|
|
|
|
4 |
p. 198-207
|
artikel
|
| 16 |
Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection
|
Gega, Arjet
|
|
|
|
4 |
p. 264-268
|
artikel
|
| 17 |
Editorial 6.4
|
Kinloch, Sabine
|
|
|
|
4 |
p.
|
artikel
|
| 18 |
Editorial
|
|
|
|
|
4 |
p. i
|
artikel
|
| 19 |
Editorial Board
|
|
|
|
|
4 |
p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
|
|
4 |
p.
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
|
4 |
p.
|
artikel
|
| 22 |
Editorial JVE 8.4
|
|
|
|
|
4 |
p.
|
artikel
|
| 23 |
Editorial JVE 9.4
|
|
|
|
|
4 |
p.
|
artikel
|
| 24 |
Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection
|
Ho, Ya-Chi
|
|
|
|
4 |
p. 229-231
|
artikel
|
| 25 |
Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV
|
Liu, Wang-Da
|
|
|
|
4 |
p.
|
artikel
|
| 26 |
‘Fear overcome by love’: why I participated in HIV cure research
|
Hawley, Clark
|
|
|
|
4 |
p. 248-249
|
artikel
|
| 27 |
From early AIDS vaccine to HIV cure research with analytical treatment interruption trials: a study participant testimonial
|
Freshwater, William
|
|
|
|
4 |
p. 231-233
|
artikel
|
| 28 |
Hepatitis B and HIV-1 2019 IAS Cure Forum: lessons and benefits from interdisciplinary research
|
Paximadis, M.
|
|
|
|
4 |
p. 234-244
|
artikel
|
| 29 |
Hepatitis B prevalence and associated factors in adults presenting for infection screening in northern Thailand
|
Salvadori, Nicolas
|
|
|
|
4 |
p.
|
artikel
|
| 30 |
Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
|
Mohamed, Rosmawati
|
|
|
|
4 |
p. 253
|
artikel
|
| 31 |
Higher risks of mother-to-child HIV transmission in countries with lower HIV prevalence: UNAIDS 2013 results for 32 countries with generalised epidemics
|
Hill, Andrew
|
|
|
|
4 |
p. 257-263
|
artikel
|
| 32 |
Highlights from the BHIVA Satellite Symposium, IAS Conference, Paris, France, July 2017: ‘Tougher times: adapting to increasing demand with declining resources’
|
|
|
|
|
4 |
p. 250-252
|
artikel
|
| 33 |
Highlights from the 22nd International AIDS Conference (AIDS 2018), 22–27 July 2018, Amsterdam, the Netherlands
|
Psomas, Christina K.
|
|
|
|
4 |
p. 238-247
|
artikel
|
| 34 |
Highlights from the 9th IAS Conference on HIV Science, 23–26 July 2017, Paris, France
|
Psomas, Christina K.
|
|
|
|
4 |
p. 242-249
|
artikel
|
| 35 |
Highlights from the 9th International Workshop on Pediatrics 21–22 July 2017, Paris France
|
|
|
|
|
4 |
p. 253-261
|
artikel
|
| 36 |
Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA
|
Joseph, J.e.y.m.o.h.a.n.
|
|
|
|
4 |
p. 243-250
|
artikel
|
| 37 |
Highlights of the HIV cure session, 19th European AIDS Clinical Society (EACS) Conference, 18-21 October 2023, Warsaw, Poland
|
Psomas, Christina K.
|
|
|
|
4 |
p.
|
artikel
|
| 38 |
Highlights of the 10th International AIDS Society (IAS) Conference on HIV Science, 21–25 July 2019, Mexico City, Mexico
|
Psomas, Christina K.
|
|
|
|
4 |
p. 245-252
|
artikel
|
| 39 |
High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
|
Hill, Andrew
|
|
|
|
4 |
p. 200-203
|
artikel
|
| 40 |
HIV cure research community engagement in North Carolina: a mixed-methods evaluation of a crowdsourcing contest
|
Mathews, Allison
|
|
|
|
4 |
p. 223-228
|
artikel
|
| 41 |
HIV cure research: print and online media reporting in Australia
|
Power, Jennifer
|
|
|
|
4 |
p. 229-235
|
artikel
|
| 42 |
HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence
|
Maldarelli, Frank
|
|
|
|
4 |
p. 237-244
|
artikel
|
| 43 |
HIV persistence in the CNS: the final frontier for a cure?
|
Lewin, S.h.a.r.o.n.R.
|
|
|
|
4 |
p. 242
|
artikel
|
| 44 |
HIV self-testing among men who have sex with men in China: a qualitative implementation research study
|
Liu, Fengying
|
|
|
|
4 |
p. 220-224
|
artikel
|
| 45 |
Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
|
Wali, Laxmikant
|
|
|
|
4 |
p.
|
artikel
|
| 46 |
How can we achieve universal access to low-cost treatment for HIV?
|
Hill, Andrew M.
|
|
|
|
4 |
p. 193-197
|
artikel
|
| 47 |
How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP
|
Pilkington, Victoria
|
|
|
|
4 |
p. 215-224
|
artikel
|
| 48 |
Hypothetical questionnaires may overestimate willingness to participate in HIV cure research: Comparison of a cross-sectional survey to actual willingness to participate in an HIV cure study in the Netherlands
|
Prins, Henrieke A.B.
|
|
|
|
4 |
p.
|
artikel
|
| 49 |
IAS Towards an HIV Cure Symposium: people focused, science driven 18–19 July 2015, Vancouver, Canada
|
Fidler, Sarah
|
|
|
|
4 |
p. 276-281
|
artikel
|
| 50 |
Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model
|
Endo, Yukinori
|
|
|
|
4 |
p.
|
artikel
|
| 51 |
Impact of COVID-19 on people living with HIV: A review
|
Prabhu, Sandeep
|
|
|
|
4 |
p.
|
artikel
|
| 52 |
Impact of hepatitis B vaccination programs in Vietnam evaluated by estimating HBsAg prevalence
|
Komada, Kenichi
|
|
|
|
4 |
p.
|
artikel
|
| 53 |
Impact of orphan status on HIV treatment outcomes and retention in care of children and adolescents in Asia
|
Huy, B.u.i.V.u.
|
|
|
|
4 |
p. 227-231
|
artikel
|
| 54 |
Incentivized self-vaccination for global measles eradication
|
Sievers, Benjamin L.
|
|
|
|
4 |
p.
|
artikel
|
| 55 |
Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy
|
Rozera, Gabriella
|
|
|
|
4 |
p.
|
artikel
|
| 56 |
International Congress on Targeting Ebola 28–29 May 2015, Pasteur Institute, Paris
|
Kinloch-de Loës, Sabine
|
|
|
|
4 |
p. 282-283
|
artikel
|
| 57 |
InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF/emtricitabine in London: an analysis of outcomes in 641 patients
|
Aloysius, Isaac
|
|
|
|
4 |
p. 218-222
|
artikel
|
| 58 |
Is pricing of dolutegravir equitable? A comparative analysis of price and country income level in 52 countries
|
Sim, Joel
|
|
|
|
4 |
p. 230-237
|
artikel
|
| 59 |
Is the human T-cell lymphotropic virus type 2 in the process of endogenization into the human genome?
|
Casseb, Jorge
|
|
|
|
4 |
p.
|
artikel
|
| 60 |
Lassa fever outbreak in adolescents in North Central Nigeria: report of cases
|
Akhiwu, H.O.
|
|
|
|
4 |
p. 225-227
|
artikel
|
| 61 |
Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study
|
Landolt, Nadia Kancheva
|
|
|
|
4 |
p. 204-207
|
artikel
|
| 62 |
Modelling the impact of different testing strategies for HCV infection in Switzerland
|
Sadeghimehr, Maryam
|
|
|
|
4 |
p. 191-203
|
artikel
|
| 63 |
Novel immunological strategies for HIV-1 eradication
|
Jülg, B.
|
|
|
|
4 |
p. 232-236
|
artikel
|
| 64 |
Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research
|
Dubé, Karine
|
|
|
|
4 |
p. 250-256
|
artikel
|
| 65 |
Patient acceptability of, and attitudes towards, hepatitis B cure research – A scoping review and identification of knowledge gaps
|
Mohtashemi, Neaka
|
|
|
|
4 |
p.
|
artikel
|
| 66 |
Population measles seroprevalence: Heterogeneity by birth-year cohort
|
Santacruz-Sanmartin, Eduardo
|
|
|
|
4 |
p.
|
artikel
|
| 67 |
Prevalence of hepatitis C virus antibody among university students in Nigeria
|
Omolade, Olabowale
|
|
|
|
4 |
p. 228-229
|
artikel
|
| 68 |
Quantifying integrated SIV-DNA by repetitive-sampling Alu-gag PCR
|
Mavigner, Maud
|
|
|
|
4 |
p. 219-226
|
artikel
|
| 69 |
Re-examining the HIV ‘functional cure’ oxymoron: Time for precise terminology?
|
Dubé, Karine
|
|
|
|
4 |
p.
|
artikel
|
| 70 |
Regulatory T cells: the ultimate HIV reservoir?
|
Rocco, Joseph
|
|
|
|
4 |
p. 209-214
|
artikel
|
| 71 |
Substantial uneven proliferation of CD4+ T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir
|
Tettamanti Boshier, Florencia A.
|
|
|
|
4 |
p.
|
artikel
|
| 72 |
Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving
|
Popping, Stephanie
|
|
|
|
4 |
p. 179-190
|
artikel
|
| 73 |
The build-up of stock of stable integrated proviruses overtime explains the difficulty in reducing HIV-1 DNA levels when treatment is initiated at the chronic stage of the infection
|
Mchantaf, Gilbert
|
|
|
|
4 |
p.
|
artikel
|
| 74 |
The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014
|
Chaivooth, Suchada
|
|
|
|
4 |
p. 192-199
|
artikel
|
| 75 |
The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
|
Mehraj, Vikram
|
|
|
|
4 |
p. 212-217
|
artikel
|
| 76 |
The hepatitis C treatment revolution: how to avoid Asia missing out
|
Walsh, Nick
|
|
|
|
4 |
p. 272-275
|
artikel
|
| 77 |
The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis
|
Freedberg, Kenneth A.
|
|
|
|
4 |
p. 245-249
|
artikel
|
| 78 |
The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample
|
Freeland, Catherine
|
|
|
|
4 |
p.
|
artikel
|
| 79 |
The latest science from the IAS Towards an HIV Cure Symposium
|
Mann, J.a.c.l.y.n.
|
|
|
|
4 |
p. 235-241
|
artikel
|
| 80 |
The role of miR-29a in HIV-1 replication and latency
|
Frattari, Giacomo
|
|
|
|
4 |
p. 185-191
|
artikel
|
| 81 |
Time for revolution? Enhancing meaningful involvement of people living with HIV and affected communities in HIV cure-focused science
|
Lau, Jillian S.Y.
|
|
|
|
4 |
p.
|
artikel
|
| 82 |
Towards a scalable HIV cure research agenda: the role of co-infections
|
Sereti, Irini
|
|
|
|
4 |
p. 269-271
|
artikel
|
| 83 |
Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
|
Gatechompol, Sivaporn
|
|
|
|
4 |
p. 225-230
|
artikel
|
| 84 |
Twin pregnancy in a liver transplant recipient with HIV infection
|
Van Schalkwyk, M.C.I.
|
|
|
|
4 |
p. 232-234
|
artikel
|
| 85 |
Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom
|
Lee, Ming J.
|
|
|
|
4 |
p.
|
artikel
|
| 86 |
Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya
|
Downs, Louise O.
|
|
|
|
4 |
p.
|
artikel
|
Tijdschrift beschrijving